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Two proteinases which belong to the tissue kallikrein family were purified from rat submaxillary glands. These proteinases correspond to the prod- 
ucts of the RSKG-7 and the rGK8 genes, as shown by the comparison of their partial amino-acid sequence with that deduced from nucleotide 
sequences. These two proteinases, kallikrein k7 and kallikrein k8, exhibit a marked preference for cleavage after arginyl residues. However, their 
overall specificities towards synthetic fluorogenic substrates differ significantly from each other and from that of true tissue kallikrein. Kallikrein 
k7 is strongly inhibited by soybean trypsin inhibitor, whereas kallikrein k8 is not. These data, demonstrating the individual specificity of these 
kallikrein-like proteinases, uggest hat they could be involved in the processing of peptides other than kinins. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
The kallikrein gene family comprises a series of 
closely related genes, the number of which varies great- 
ly from one species to another (see [I] for a review). 
The close relationship between the genes in this family 
may explain why only a few of the proteins they encode 
have been clearly identified. For example, only two 
protein products, tissue kallikrein and tonin, have been 
unambiguously assigned to members of the gene family 
in the rat [2,3]. Several other kallikrein-like proteinases 
have been reported, but none has been correlated with 
a cloned gene or mRNA [4-lo]. The fact that 
kallikrein-like proteinases could be involved in the pro- 
cessing of peptides other than kinin-derived peptides 
prompted us to purify and analyse these proteinases. 
We will focus here on the purification and characteriza- 
tion of two of these proteinases from rat submaxillary 
glands. These enzymes appear to be the translation pro- 
ducts of the RSKG-7 and rGK8 genes [ 11,121; they have 
been provisionally called kallikrein k7 and kallikrein 
k8, but their biological function is, as yet, unknown. 
As a first step in this direction, we have investigated the 
enzymatic properties, particularly the cleavage 
specificity, of these proteinases and compared them to 
those of true tissue kallikrein, reported here as 
kallikrein kl . 
Kallikreins k7 and k8 were purified from a homogenate of about 
20 g of submaxillary glands excised from male Wistar rats after com- 
plete exsanguination. This homogenate was treated with 0.5% (w/v) 
sodium deoxycholate, equilibrated with 0.01 M phosphate buffer, 
pH 6.0, 0.1 M sodium chloride and applied to a DEAE-A50 column 
essentially as described by Brandtzaeg et al. [4]. Unbound fractions 
were divided into 5 pools, the third and the fifth were used as sources 
of kallikrein k7 and kallikrein k8, respectively. These two pools, 
denoted A and B in Fig. la, were concentrated and passed through an 
aprotinin-Sepharose column equilibrated in 0.05 M Tris/HCl buffer, 
pH 8.3, 0.025 M calcium chloride, 0.15 M sodium chloride. The 
material retained on the column was eluted with 0.05 M formic acid 
pH 2.4, dialysed against the equilibration buffer, then fractionated 
by reverse phase chromatography on a C4 cartridge using a 060% 
acetonitrile gradient in 0.075C TFA (Fig. lb). Eluted fractions were 
immediately dialysed against 0.05 M Tris/HCl buffer pH 8.3,0.15 M 
NaCl on a PD 10 column, concentrated, analysed by isoelectric 
focusing [13] or SDS polyacrylamide gel electrophoresis [14], and 
stored at -70°C. 
N-terminal sequence analyses were performed on an Applied 
Biosystems 477A protein sequencer and the PTH derivatives were 
identified using an on-line associated model 120A analyser. Samples 
were reduced, pyridylethylated and fractionated by reverse phase 
chromatography on a C8 cartridge using a 060% acetonitrile gra- 
dient in 0.075% TFA, to separate the light and heavy chains of both 
proteinases. About 100 pmol of product was used for N-terminal 
analysis. 
Active site titrations of kallikreins k7 and k8 were performed as 
described previously [14] using the bovine lung inhibitor aprotinin, 
first titrated by bovine trypsin. 
Correspondence address: F. Gauthier, University Francois Rabelais, 
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The active site concentration of trypsin was determined as describ- 
ed by Chase and Shaw [15] using pNPGB. Briefly, proteinases (final 
concentrations in the 0.1 CM range) were incubated for 20 min with 
increasing amounts of aprotinin before starting the reaction with 
10 ~1 0.2 mM Z-Phe-Arg-NHMec and recording the fluorescence at 
460 nm .
Abbreviations: Boc, t-butyloxycarbonyl; Bz, benzoyl; NHMec, 
7-amido-4-methylcoumarin; Z, benzyloxycarbonyl; SBTI, soybean 
trypsin inhibitor; pNPGB, p-nitrophenyl-p’-guanidinobenzoate 
The efficiency of kallikreins kl, k7 and k8 towards synthetic 
fluorogenic substrates was determined by calculating the values of the 
second order rate constant k,,,/K,. These values were determined 
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Fig. 1. Purification of kallikreins k7 and k8 from rat submaxillary glands: (a) Unbound material eluted from DEAE-A50 chromatography. Pools 
A and B were used to further purify kallikrein k7 and kallikrein k8 on aprotinin-Sepharose. (b) Reverse phase chromatography on a BU300 car- 
tridge of the aprotinin-bound material corresponding to DEAE-A50 fraction B. Kallikrein k8 was eluted first; the second peak corresponds to 
kallikrein k7. The relative sizes of the peaks were reversed when fraction A was used as starting material. Other experimental details are given 
under section 2. 
under first order conditions, i.e. with initial concentrations of 
substrates low enough in front of K,,, to be neglected in the lower part 
of the Michaelis equation, which therefore reduces to: -dS/dr= 
(k&K,) Et S [16]. The reaction was monitored up to completion and 
the above equation was integrated to determine the half-time of the 
reaction, which is related to k&K, as follows: kcat/K,,,=0.693/Et 
tlj2. About four experimental t1/2 values could be measured from a 
single recording of the rate of hydrolysis of a given substrate. Their 
mean value was used to calculate k&K,,, . Et values were calculated 
from the titration studies. Preliminary studies on the inhibition of 
kallikreins k7 and k8 by the soybean trypsin inhibitor were done, 
working with final enzyme concentrations in the 0.1 micromolar 
range and a IO-fold molar excess of inhibitor. Mixtures were in- 
cubated for 10 min before starting the reaction by adding fluorescent 
substrate (1 pM final). 
3. RESULTS AND DISCUSSION 
The great similarity among proteinases of the 
kallikrein family seriously hampers their identification 
and characterization. They often share common 
epitopes, which makes them difficult to differentiate 
with polyclonal antisera [ 171. Their molecular weight is 
also very similar, but the net electric charge of some of 
them is rather different so that whole submaxillary 
gland extract can be fractionated by anion exchange 
chromatography. This method, originally reported by 
Brandtzaeg et al. [4], was used as the initial step from 
which at least five different kallikrein-like proteinases 
may be purified [unpublished]. Kallikreins k7 and k8 
were purified as described above; the main steps are 
shown in Fig. 1. Both appear as two bands upon SDS 
gel electrophoresis. The bands from k7 had apparent 
M, of 19,000 and 9,000 for the former, while those for 
k8 were 18,000 and 10,000 (Fig.2). Kallikrein kl ap- 
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peared as a single band of 38,000 under the same condi- 
tions (not shown). The separation of kallikreins k7 and 
k8 into two chains probably results from an internal, 
possibly autolytic, cleavage in the region of the so call- 
ed “kallikrein loop” [18]. However, such a cleavage in 
tissue kallikrein would not significantly modify the 
kininogenase activity [19]. The net electric charges of 
kallikreins k7 and k8 also clearly differ from that of 
tissue kallikrein. Isoelectric focusing gave a pHi of 4.0 
for kallikrein kl, whereas values of 5.2 and 5.1 were 
found for kallikreins k7 and k8 respectively. 
Fig.2. SDS gel electrophoresis (15%) of kallikrein k7 (a), and k8 (b) 
after reduction. Each well contained about 3 cg protein. Numbers in- 
dicate Mr/103 of markers. 
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Table I 
Amino acid sequences of the light and heavy chains of kallikrein k7 and kallikrein k8 
June 1990 
KALLIKREIN Kl: 
Q 
10 20 
light chain: V I-G-G-Y-K-C-E-K-N-S-Q--------- 
93 
heavy chain: K-P-G~D~S-N-D-L-N-L-L-H-L~P-A-D-I-T-D-G-V-K-V-I------- 
KALLIKREIN KS: 
10 
I-G-G-F-N-C-E-K-N-S-Q-P-W-Q-V-A-V-Y-------- 
heavy chain: K-P-G~D~S-N-D-L-"-L-L-K,"-L~P-A-D-I-T-D-G-V-K-V------- 
Residues which differ from one proteinase to the other are boxed 
The material eluted from C4 reverse phase 
chromatography was used for sequence analysis after 
reduction/pyridylethylation and reverse phase chro- 
matography on a C8 cartridge. About 100 pmol of light 
and heavy chains were analysed and the sequences are 
given in Table I. Clearly, these sequences represent he 
products of the RSGK-7 gene described by Chen et al. 
[ll], and of the rGK8 gene described by Brady et al. 
[ 121, since there was complete sequence homology be- 
tween the partial amino acid sequences reported here 
and those deduced from the nucleotide sequence 
[ll, 121. Kallikrein k7 could be also similar to the Pro- 
teinase A described by Kato et al. [8], the partial se- 
quences of which differ by only two residues from that 
deduced from the RSKG-7 nucleotide sequence. The 
amino acid sequences of kallikreins k7 and k8 are very 
similar to that of true kallikrein. All three possess the 
main determinants which define serine proteinases and 
the specificity for a preferential cleavage after arginyl 
residues. Whether kallikreins k7 and k8 also exhibit the 
secondary specificity which characterizes true kallikrein 
[20] is of major importance for understanding their 
biological function. This restricted specificity, which 
explains why tissue kallikrein specifically excises the 
vasoactive peptide kallidin from kininogen without fur- 
ther proteolysis, is mainly due to the residue in P2 posi- 
tion (according to the nomenclature of Schachter and 
Berger [21]) adjacent to the arginyl residue [22]. The 
presence of a bulky hydrophobic residue such as 
Table II 
k&K, values for the hydrolysis of fluorogenic substrates by 
kallikreins kl, k7 and k8 (l/(mM . s)) 
Kallikrein kl Kallikrein k7 Kallikrein k8 
Pro-Phe-Arg-NHMec 171 474 34 
Z-Phe-Arg-NHMec 57 424 56 
Boc-Phe-Ser-Arg-NHMec < 5 223 <5 
Z-Arg-Arg-NHMec <5 <5 <5 
Boc-Leu-Gly-Arg-NHMec < 5 129 6 
Bz-Phe-Val-Arg-NHMec 17 709 33 
Boc-Val-Pro-Arg-NHMec < 5 345 20 
phenylalanyl or leucyl at this position in the substrate 
is most favourable for interaction with tissue kallikrein 
[22]. We therefore investigated the kinetic properties of 
kallikreins k7 and k8, as well as those of rat tissue 
kallikreins kl, towards synthetic fluorogenic substrates 
in which the nature of the residue in P2 position varied 
while the PI Arg residue was conserved. Titrated en- 
zymes were used to provide a direct comparison of pro- 
teinase reactivity towards a given substrate. The results 
are shown in Table II. As previously reported for por- 
cine tissue kallikrein, rat submaxillary kallikrein kl 
preferentially accommodates those substrates with a 
Phe in position P2 and reacts poorly with substrates 
which have polar residues in this position. A similar 
restricted specificity was found for kallikrein k8 which 
cleaved substrates with Ser or Gly in position P2 
poorly. 
However, this enzyme differs from true kallikrein in 
that it preferentially cleaves Z-Phe-Arg-NHMec rather 
than the kininogen-like kallikrein substrate Pro-Phe- 
Arg-NHMec. Its specificity as a kininogenase may thus 
be questionable. At variance with these results, the 
specificity of kallikrein k7 is not as limited as that of 
kallikrein kl or kallikrein k8, since it can accommodate 
substrates with Ser, Gly or Pro in position P2 (Table 
II). Pro-Phe-Arg-NHMec, though quickly hydrolysed 
by kallikrein k7, is not the best substrate of this pro- 
teinase which preferentially accommodates a valyl 
residue in P2 (Table II). These results agree with those 
from structural analyses of porcine tissue kallikrein 
defining the critical residues involved in substrate bin- 
ding [23]. Tyr-93 and Tryp-205 are key residues which 
give kallikrein its P2 specificity by forming a hydro- 
phobic sandwich that traps nonpolar aminoacids in the 
P2 position [ 181. Both are found in true kallikrein and 
in kallikrein k8 but not in kallikrein k7 Ill]. The 
presence of a histidyl residue in postion 93 of kallikrein 
k7 could explain its broader specificity. This structural 
change in kallikrein k7 could also be related to the fact 
that this enzyme, but not kallikreins kl and k8, is in- 
hibited by SBTI. It may be therefore concluded that, in 
spite of their obvious structural and functional similar- 
139 
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ities, these enzymes have sufficiently different catalytic 
properties for each to have unique substrate speci- 
ficities. The tissue localization of these proteinases 
together with their different levels of expression pro- 
bably help define the specificity of each enzyme. Pl 
mRNA, coding for kallikrein k8, has been found only 
in the rat prostate and submaxillary glands [ 121, 
whereas the RSKG7 gene encoding kallikrein k7, is ex- 
pressed in the kidney and submaxillary glands [ 111. 
Definition of the precise substrate specificities of these 
proteinases using protein substrates, together with a 
knowledge of their tissue and cell distributions, will 
provide a basis for identifying their physiological 
substrate. 
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